Watch-and-wait treatment for abnormal cervix cells before future pregnancy
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial studies a “conservative” (less immediate) approach to a specific abnormal cervix finding to see if it can be managed safely for people who want future pregnancies. It uses close follow-up visits instead of immediate procedures for certain results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are able to get pregnant now (reproductive age) and you want future pregnancies
- You agree to try conservative management (watchful follow-up) rather than immediate treatment
- You can come to all planned follow-up appointments
- Your colposcopy must show the abnormal area clearly (type 1 or 2) with grade 2 changes fully visible
- The abnormal area must not extend beyond 50% of the cervix surface, and there must be no gland-type abnormal cells in the results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at doing a diagnostic cervical conization (a cone-shaped tissue biopsy) when HPV remains persistent and there are warning signs, but initial pathology does not show precancer. It aims to find hidden precancer earlier or better understand HPV-related changes that were missed.
This study follows women with an early abnormal cervix cell change (CIN2/CIN2-3) to see how HPV DNA “integration” relates to whether the condition improves or worsens. It may help doctors better predict prognosis and guide safer monitoring, especially if you want to become pregnant.
This trial tests pembrolizumab (an immune treatment) to see if it can treat high-grade abnormal cells of the cervix (CIN 2/3 or carcinoma in situ). You may need biopsies during the study and a planned procedure after about 24 weeks to remove or sample the cervix tissue.
This study looks for ways to predict who will respond to imiquimod cream for precancerous cervical cell changes (CIN2 or CIN3). Results may help doctors choose the best treatment approach and better plan follow-up.
This trial tests whether a topical cream called TCA (trichloroacetic acid) can effectively treat low-grade cervical lesions (LSIL) found after an abnormal Pap or HPV test. It may be an option for women who want to avoid more invasive procedures.
This study tests a light-activated therapy (HAL-PDT) to treat high-grade cervical dysplasia before considering surgery. It compares the response to standard surgery, aiming to see if the light therapy can help avoid or delay more invasive procedures.
Hear when a new Cervical Intraepithelial Neoplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.